Research

Diagnostics and scaffolding

Tumor cells in cockle tissue. (Credit: Antonio Villalba and María J. Carballal)

Demonstrate the need for cancer in the blood, explore researcher XOSOM
Posted: 12 July 2016
Researchers are exploring ways to gain insight into cancer and to use diagnostic tools for patients using vascals called exosomes.

Image-guided biopsy can increase the risk of high-risk tumors for diagnosis of prostate cancer
Posted: 27 January 2015
In the largest study on the date of image-guided techniques to identify suspected areas of prostate biopsy, researchers have detected high-risk prostate cancer compared to the potential of this technique, which is the absence of the current standard of absent prostate biopsy with.

NCI has established genomic data commons to identify the target of cancer molecular subtype and potential drug
Posted: December 2, 2014
NCI is establishing genomic data commons to store, analyze and distribute cancer genomics data generated by NCI and other research organizations. GDC will provide an interactive system for researchers' data with the goal of furthering the molecular diagnosis of cancer and will suggest potential therapeutic targets based on genomic information.

The Benefits Of Appearing In Many Cancer Genomes: A Perspective
Updated: 12 August 2014
Cancer is not a single unit; rather, it is more than one hundred complex and distinct diseases, most of which require the type of cancer a unique treatment strategy. TCGA researchers have developed a formal project for cross tumor analysis, which is called panic cancer. Its goal is to collect the TCGA's wealth of data in tumor types, analyze those data and analyze them, and finally, both analyzes and data available independently.

Negative side of clinical imaging
Posted: January 26, 2010
An article about calculation tomography and nuclear imaging processes and radiation performance during the risk of cancer. Several studies released in 2009 have helped to measure the risks and increasing use of these clinical imaging methods.